Meta Health (SGX:5DX) has mutually agreed to extend the expiration date of its non-binding term sheet for the potential acquisition of a 30% stake in Aios Bio Sciences Pte. Ltd., according to a Thursday filing on the Singapore Exchange.
The original term sheet, signed with Aios shareholder Davin Ng and other vendors to be identified, expired on Feb. 2.
Meta Health said it remains in negotiations and continues due diligence on Aios Bio Sciences, a life sciences firm, to assess the viability of the deal before signing a definitive agreement.
The parties have retrospectively extended the term sheet's expiration to May 3. However, Meta Health cautioned there is no certainty the acquisition will be completed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.